About WordPress
WordPress.org
Documentation
Support
Feedback
Log In
Register
Search
Sign in
Sign up
Search for:
Colorectal Cancer
View Course details
·
January 10, 2023
Course Content
Adding a CTLA-4 Inhibitor in combination with Anti-PD1 and Multi-Kinase inhibitor led to an unprecedented response rate of 40% in chemotherapy-resistant metastatic colorectal cancer
Preview this Course
Not Enrolled
Login to Enroll
Free
Course Includes
1 Lesson
Login
Accessing this course requires a login. Please enter your credentials below!
Email Address
Password
Remember Me
Lost Your Password?
Register
Don't have an account? Register one!
Register an Account
Username
Email
Registration confirmation will be emailed to you.
